Molecular basis of the association of H208Y and thymidine analogue resistance mutations M41L, L210W and T215Y in the HIV-1 reverse transcriptase of treated patients-Reference-Cited by-同舟云学术

Molecular basis of the association of H208Y and thymidine analogue resistance mutations M41L, L210W and T215Y in the HIV-1 reverse transcriptase of treated patients

Published:2014-06 Issue: Volume:106 Page:42-52
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Betancor Gilberto,Nevot María,Mendieta Jesús,Gómez-Puertas Paulino,Martínez Miguel A.,Menéndez-Arias Luis

Funder

Spanish Ministries of Economy and Competitiveness

Health, Social Services and Equality

Fundación Ramón Areces

European Social Fund

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference49 articles.

1. Increased thermostability and fidelity of DNA synthesis of wild-type and mutant HIV-1 group O reverse transcriptases;Álvarez;J. Mol. Biol.,2009

2. Phenotypic mechanism of HIV-1 resistance to 3′-azido-3′-deoxythymidine (AZT): increased polymerization processivity and enhanced sensitivity to pyrophosphate of the mutant viral reverse transcriptase;Arion;Biochemistry,1998

3. Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy;Betancor;Retrovirology,2012

4. Mechanisms involved in the selection of HIV-1 reverse transcriptase thumb subdomain polymorphisms associated with nucleoside analogue therapy failure;Betancor;Antimicrob. Agents Chemother.,2010

5. An integrated system to study multiply substituted human immunodeficiency virus type 1 reverse transcriptase;Boretto;Anal. Biochem.,2001

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A survey of resistance mutations to reverse transcriptase inhibitors (RTIs) among HIV-1 patients in northeast of Iran;MOL BIOL RES COMMUN;2024

2. Islatravir: evaluation of clinical development for HIV and HBV;Expert Opinion on Investigational Drugs;2024-01-26

3. Analysis of the Zidovudine Resistance Mutations T215Y, M41L, and L210W in HIV-1 Reverse Transcriptase;Antimicrobial Agents and Chemotherapy;2015-08-31

4. Drug Resistance in Non-B Subtype HIV-1: Impact of HIV-1 Reverse Transcriptase Inhibitors;Viruses;2014-09-24